Follicular lymphoma laboratory findings: Difference between revisions

	Follicular lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Follicular lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-Ray
CT scan
MRI
Echocardiography or Ultrasound
Biopsy
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Follicular lymphoma laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Follicular lymphoma laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Follicular lymphoma laboratory findings
CDC on Follicular lymphoma laboratory findings
Follicular lymphoma laboratory findings in the news
Blogs on Follicular lymphoma laboratory findings
Directions to Hospitals Treating Follicular lymphoma
Risk calculators and risk factors for Follicular lymphoma laboratory findings

Revision as of 18:47, 1 September 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Laboratory tests for follicular lymphoma include complete blood count (CBC), blood chemistry studies, cytogenetics studies, flow cytometry, immunohistochemistry, FISH, genetic testing, and immunophenotyping.

Laboratory tests for follicular lymphoma include^[1]:

Immunohistochemistry
FISH
Genetic testing
Immunophenotyping: BCL-2+, BCL6+, CD5-, CD10+, CD19, CD20, CD22, CD43, CD79a, heavy and light chains rearranged, t(14;18)(q32:q21)-85% with rearrangement of BCL-2 gene.

↑ National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{AS}}
 ==Overview==
-Laboratory tests of follicular lymphoma include histologic confirmation, [[FISH]], [[genetic testing]], and [[immunophenotyping]].
+Laboratory tests for follicular lymphoma include [[complete blood count]] (CBC), blood chemistry studies, cytogenetics studies, [[flow cytometry]], [[immunohistochemistry]], [[FISH]], [[genetic testing]], and [[immunophenotyping]].
 ==Laboratory tests==
-Laboratory tests of follicular lymphoma include<ref name=”seer”>National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov</ref>:
+Laboratory tests for follicular lymphoma include<ref name=”seer”>National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov</ref>:
-*Histologic confirmation
+* [[Complete blood count]] (CBC)
-*[[FISH]]
+* Blood chemistry studies
-*[[Genetic testing]]
+* [[Cytogenetics studies]]
-*[[Immunophenotyping]]:'' [[BCL-2]]''+, BCL6+, [[CD5]]-, CD10+, [[CD19]], [[CD20]], [[CD22]], [[CD43]], [[CD79a]], heavy and light chains rearranged, t(14;18)(q32:q21)-85% with rearrangement of ''[[BCL-2]]'' gene.
+* [[Flow cytometry]]
+* [[Immunohistochemistry]]
+* [[FISH]]
+* [[Genetic testing]]
+* [[Immunophenotyping]]:'' [[BCL-2]]''+, BCL6+, [[CD5]]-, CD10+, [[CD19]], [[CD20]], [[CD22]], [[CD43]], [[CD79a]], heavy and light chains rearranged, t(14;18)(q32:q21)-85% with rearrangement of ''[[BCL-2]]'' gene.
 ==References==